9-35088825-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032634.4(PIGO):c.*267C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 370,864 control chromosomes in the GnomAD database, including 263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 220 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 43 hom. )
Consequence
PIGO
NM_032634.4 3_prime_UTR
NM_032634.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.15
Genes affected
PIGO (HGNC:23215): (phosphatidylinositol glycan anchor biosynthesis class O) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 9-35088825-G-C is Benign according to our data. Variant chr9-35088825-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 366749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0975 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGO | NM_032634.4 | c.*267C>G | 3_prime_UTR_variant | 11/11 | ENST00000378617.4 | NP_116023.2 | ||
PIGO | NM_001201484.2 | c.*267C>G | 3_prime_UTR_variant | 13/13 | NP_001188413.1 | |||
PIGO | NM_152850.4 | c.*267C>G | 3_prime_UTR_variant | 12/12 | NP_690577.2 | |||
PIGO | XM_005251619.4 | c.*267C>G | 3_prime_UTR_variant | 11/11 | XP_005251676.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGO | ENST00000378617.4 | c.*267C>G | 3_prime_UTR_variant | 11/11 | 1 | NM_032634.4 | ENSP00000367880 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0287 AC: 4362AN: 152142Hom.: 221 Cov.: 32
GnomAD3 genomes
AF:
AC:
4362
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00384 AC: 840AN: 218604Hom.: 43 Cov.: 4 AF XY: 0.00326 AC XY: 376AN XY: 115302
GnomAD4 exome
AF:
AC:
840
AN:
218604
Hom.:
Cov.:
4
AF XY:
AC XY:
376
AN XY:
115302
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0287 AC: 4368AN: 152260Hom.: 220 Cov.: 32 AF XY: 0.0272 AC XY: 2026AN XY: 74454
GnomAD4 genome
AF:
AC:
4368
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
2026
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hyperphosphatasia with intellectual disability syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at